Description
The PassMachine Medical Oncology Board Review 2020
The PassMachine Medical Oncology
Online Course v5.1, Release Date October 14, 2020, Termination Date October 13, 2023
INSTRUCTIONS:
- Download all compressed (.rar) files and put them into the same folder on your computer.
- Using WinRAR, extract the file part1.rar. This will automatically extract all other parts together.
- After extraction, run the medical-oncology-review-(v5.1).html file. This will start the lecture.
- Complete syllabus is available as a separate PDF file.
HIGH-YIELD CONTENT
LASER-FOCUSED LECTURES:Â A comprehensive library of video lectures precisely aligns to the Medical Oncology Certification and Medical Oncology MOC exam blueprints, so you focus on all exam topics and keywords with no wasted effort.
BOARD-EXPERIENCED FACULTY:Â Board-certified faculty are experienced in teaching Medical Oncology board exam preparation. Thus, every lecture is up to date, medically accurate, and entirely board-relevant.
MEDICAL ONCOLOGY STUDY GUIDE: The included PDF provides the complete course syllabus, hundreds of pages long.
Intended Audience:Â Oncologists
Learning Objectives:
Upon completion of this program, participants should be able to:
- Assess diagnosis, staging and prognostic factors of breast cancer.
- Explain the different types of gynecologic cancer.
- Describe basic pharmacological and biological principles in the management and treatment of cancer.
- Develop comprehensive management and treatment plans for genitourinary cancer including bladder, other urothelial, prostate, and renal cancer, and germ cell tumors.
- Demonstrate medical management of lung and thymic cancer and mesothelioma.
- Integrate modalities of care and ethics including treatment-related issues, complications, supportive care, survivorship, psychosocial aspects of cancer, bioethical/legal/economic issues, and communication skills.
Content :
Hematologic Neoplasms
Acute Leukemia and Myelodysplasia (1 Hour)
Peter Silberstein, MD
Chronic Myeloid Leukemia and Myeloproliferative Neoplasms (1 Hour)
Peter Silberstein, MD
Chronic Lymphoproliferative Leukemias (0.5 Hours)
Peter Silberstein, MD
Multiple Myeloma and Plasma Cell Dyscrasias (1 Hour)
Peter Silberstein, MD
Non-Hodgkin Lymphoma (1.5 Hours)
Peter Silberstein, MD
Thoracic Cancer
Non-small Cell Lung Cancer (0.5 Hours)
Christine M. Bestvina, MD
Small Cell Lung Cancer and Mesothelioma and Thymus Cancer (0.25 Hour)
Christine M. Bestvina, MD
Breast Cancer
Premalignant Conditions, High-risk Factors & Carcinoma in Situ (0.5 Hours)
Skikha Jain, MD
Early-Stage Invasive Carcinoma (0.75 Hours)
Jacob Thomas, MD
Less Common Histologies and Clinical Scenarios (0.25 Hours)
Jacob Thomas, MD
Locally Advanced and Inflammatory Disease and Locally Recurrent Disease (0.25 Hours)
Jacob Thomas, MD
Metastatic Disease (1 Hour)
Jacob Thomas, MD
Genitourinary Cancer
Germ Cell Tumors (0.25 Hours)
Skikha Jain, MD
Prostate Cancer (0.75 Hours)
Skikha Jain, MD
Renal Cell Cancer (0.5 Hours)
Skikha Jain, MD
Urothelial and other Genitorourinary Cancers (1 Hour)
Skikha Jain, MD
Gynecologic Cancer
Cancer of the Cervix, Vulva, & Vagina & Other Gynecologic Malignancies (0.5 Hours)
Peter Silberstein, MD
Ovarian Cancer (1 Hour)
Peter Silberstein, MD
Gastrointestinal Cancer
Gastrointestinal: Pancreatic & Anal Cancer (1 Hour)
Efrat Dotan, MD
Gastrointestinal: Biliary/Gallbladder Cancer & Neuroendocrine Tumors (0.75 Hours)
Efrat Dotan, MD
Gastrointestinal: Colorectal Cancer (1.5 Hours)
Efrat Dotan, MD
Gastrointestinal: Gastric Cancer (1 Hour)
Efrat Dotan, MD
Gastrointestinal: Esophageal Cancer (0.75 Hours)
Efrat Dotan, MD
Gastrointestinal: Hepatocellular Carcinoma (0.5 Hours)
Efrat Dotan, MD
Skin Cancer, Sarcomas, and Unknown Primary Site
Bone and Soft Tissue Sarcomas and Unknown Primary Site Part I (0.5 Hours)
Peter Silberstein, MD
Unknown Primary Site Part II (0.5 Hours)
Peter Silberstein, MD
Melanoma and Other Skin Cancers (0.75 Hours)
Jacob Thomas, MD
Anticancer Therapeutics, Clinical Research Methodology, and Ethics
Anticancer Therapeutics (2.25 Hours)
Jacob Thomas, MD
Clinical Research Methodology and Ethics (0.5 Hours)
Jacob Thomas, MD
Principles of Allied Disciplines (0.75 Hours)
Jacob Thomas, MD
Palliative Care, Survivorship, and Communication
Cancer Pain I (0.5 Hours)
Jacob Thomas, MD
Cancer Pain II and Survivorship Issues (0.5 Hours)
Jacob Thomas, MD
Clinical Manifestations of Advanced Cancer and Its Treatment (1.5 Hours)
Peter Silberstein, MD
End-of-Life Issues (0.5 Hours)
Peter Silberstein, MD
Procedure-related Issues and Communication (0.5 Hours)
Peter Silberstein, MD
Head, Neck, Thyroid, and Central Nervous System Malignancies
Head & Neck Cancer (1.5 Hours)
Ari Rosenberg, MD
Thyroid and Salivary Gland Cancer (0.5 Hours)
Ari Rosenberg, MD
Central Nervous System Malignancies (0.5 Hours)
Ari Rosenberg, MD
Genetics and Tumor Biology
Cancer Biology, Genetics, and Tumor Immunology (0.75 Hours)
Akash Patnaik, MD
Heritable Cancer Syndromes and Cancer Epidemiology (0.5 Hours)
Akash Patnaik, MD
